Synopsis: Coronary atherosclerosis is a major cause of mortality. T29107A specific genotype of Caveolin-1 may be linked with coronary artery disease pathogenesis. Utility of this polymorphic variant as a diagnostic or prognostic marker in CAD warrants further trials on larger series.
INTRODUCTION
Coronary atherosclerosis is a major cause of mortality especially in industrialized countries.
Role of inflammatory pathways in the pathogenesis of atherosclerosis is widely accepted (1) .
In this process, accumulation and activation of monocytes and macrophages in the vessel wall constitute critical steps that in turn elicit the initial phase of plaque formation and chronic lesion progression. These reactions are followed by acute complications such as plaque rupture and thrombosis (2, 3) .
Caveolae are plasma cell membrane invaginations that are commonly found on fibroblasts, endothelial and epithelial cells. Caveolin-1 is a protein found in caveolae that functions in the intracellular signalling pathway for processes including fibrosis, vascular proliferation, wound healing, angiogenesis, tissue growth (4) (5) (6) . In addition to these physiological reactions, it can be involved in some pathological processes such as ischemia and tumour growth (7) . Previously, Testa has demonstrated that a single nucleotide polymorphism of Caveolin-1 was linked with carotid arterial media thickness in end stage renal disease patients (8) . Caveolin-1, encoded by CAV1 gene located at 7q31.1, is a marker for caveolae. It is supposed to compartmentalize various signalling molecules and serves as an organization centre (9) . Some publications have yielded that caveolae had functions in cholesterol transport and haemostasis and lipid droplet accumulation (10) .
To the extent of our knowledge, there is no study conducted on the role of Caveolin-1 genotypes in the pathogenesis of coronary artery disease (CAD) in the medical literature. The purpose of the present study was to investigate whether two polymorphic variants of Caveolin-1, namely G14713A and T29107A, may be linked with coronary artery disease.
MATERIALS AND METHODS

Study Design
This cross-sectional, clinical study was carried out in the cardiology department of our tertiary Table 1 .
Diagnosis of CAD was established with respect to coronary angiography and severity of disease was estimated according to Gensini scores (12). Gensini score constitutes as an objective method for evaluation of the severity of CAD and also provides additional information on prognosis (13).
The control group consisted of healthy adult volunteers that underwent coronary angiography for suspicion of coronary artery disease. Exclusion criteria were history of malignancy, severe congestive heart failure, valvular cardiac disease, chronic metabolic disorders such as renal or hepatic failure.
Outcome measures
Main outcome measures under concern were positivity for Cav-1 G14713A and BfaI ve Cav- Table 2 . There were no remarkable differences between two groups in terms of age (p=0.340), gender distribution (p=0.309), levels of haemoglobin (p=0.089), haematocrit (p=0.320), high density lipoproteins (p=0.215), and family history of CAD (p=0.064). Gensini scores in CAD group was determined as 33.45-26.76 (median-interquartile range).
RESULTS
Data derived from CAD and control groups in this study is demonstrated in
On the other hand, CAD group had notably increased BMI (p=0.002), serum levels of fasting glucose (p=0.009), total cholesterol (p<0.001), triglycerides (p=0.032), low density lipoproteins (p<0.001), creatinine (p=0.027) and mean platelet volumes (p<0.001).
Frequencies of diabetes mellitus (p=0.032), hypertension (p=0.009) and hyperlipidaemia (p=0.037) were significantly higher in patients with CAD.
DISCUSSION
In this study, we aimed to determine whether expression of two polymorphic variants of Caveolin-1 gene, T29107A and G14713A, were altered in CAD. Our findings indicated that T29107A, but not G14713A, was detected more frequently in CAD patients.
Clinical studies have demonstrated that statins, by involving diverse signal pathways (such as Caveolin, LOX-1, SR-B1, adenosine, etc.) may enhance the availability of endothelium derived nitric oxide. This is important as a cardiovascular defence mechanism of statins.
Therefore, Caveolin-1 seems to be involved in the functions of statins for amelioration of cardiovascular diseases and improvement of cardiovascular outcomes (14) .
Experimental studies have been performed to unveil the roles and functions of caveolae and Caveolin-1 gene (15-18) . Caveolin-knock out animal models have provided clarification of the possible functions of Caveolin-1 and caveolae in several pathologies (15) .
Caveolin-1 null mice were found to be resistant to diet-induced obesity, accompanied by increases in plasma levels of VLDL particles and triglycerides, and insulin resistance (16, 17) .
In addition, they exhibit vascular dysfunction especially with defects in endotheliumdependent contractile responses (18) .
Caveolin-1 plays role in vascular diseases and processes like sepsis, cancer and fibrosis (18) . Evidence has been found for dependence of arterial remodelling on a Caveolin-1 single nucleotide polymorphism genotype in patients with end stage renal disease (8) .
Reduced Caveolin-1 expression was detected in vascular smooth muscle cells of patients with established atheromatous disease (8) .
As far as we know, this is the first trial to identify the association between T29107A
variation of Caveolin-1 in CAD patients. Results of the present study suggest that there may be a link between a single nucleotide polymorphism of CAV1 and development of CAD.
Since CAD is accompanied by inflammatory, metabolic, vascular and systemic impairments, it is difficult to establish a direct causal relationship. Further trials in future cohorts is warranted to establish whether this gene variant is valuable as a diagnostic or prognostic biomarker.
Moreover, it must be remembered that elucidation of the effects of single nucleotide polymorphisms of Caveolin-1 may necessitate further methods such as immunohistochemistry or western blotting. Roles of each section or every nucleotide in the regulation of transcription, translation and posttranslation stages of Caveolin-1 gene may be distinct.
Complicated interactions of many metabolic, biochemical, genetic and environmental factors must be taken into account during interpretation of these results. Enlarged size of population and combined genomic and environmental trials will allow gathering more refined and realistic data for making healthier extrapolations.
To conclude, results of the present study have yielded that T29107A specific genotype of Caveolin-1 may be linked with CAD pathogenesis. Utility of this polymorphic variant as a diagnostic or prognostic marker in CAD warrants further trials on larger series. 
